| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71278 | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 488 | DDX0420A488-100 | |||
| Alexa Fluor 546 | DDX0420A546-100 | |||
| HRP | DDX0420HRPO | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52494-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52448-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-03252-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35098-1mg | |||
| Carrier-Free | NBP2-35098-100ug | |||
| Carrier-Free | NBP2-35098-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35079-1mg | |||
| Carrier-Free | NBP2-35079-100ug | |||
| Carrier-Free | NBP2-35079-500ug | |||
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0012.jpg "Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)")
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0001.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0002.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0003.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0004.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0005.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human lung tissue.(Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0006.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0007.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0008.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0009.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0010.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0011.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0013.jpg)
![ELISA: Mouse BNP ELISA Kit (Colorimetric) [NBP2-70011] - Samples were spiked with high concentrations of Mouse BNP and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp2-70011_mouse-bnp-elisa-kit-colorimetric-132202416235783.jpg "ELISA: Mouse BNP ELISA Kit (Colorimetric) [NBP2-70011] - Samples were spiked with high concentrations of Mouse BNP and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.")
![ELISA: Mouse BNP ELISA Kit (Colorimetric) [NBP2-70011] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp2-70011_mouse-bnp-elisa-kit-colorimetric-4320248595193.jpg)
![Immunohistochemistry-Frozen: CCL20/MIP-3 alpha Antibody (206D9.05) [DDX0420P-100] - Analysis using the HRP conjugate of DDX0420P-100. Analysis of frozen human tonsil tissue probed with DDX0420.](http://images.novusbio.com/fullsize/CCL20-MIP-3-alpha-Antibody-206D9-05-Immunohistochemistry-Frozen-DDX0420P-100-img0009.jpg "Immunohistochemistry-Frozen: CCL20/MIP-3 alpha Antibody (206D9.05) [DDX0420P-100] - Analysis using the HRP conjugate of DDX0420P-100. Analysis of frozen human tonsil tissue probed with DDX0420.")
![Blocking/Neutralizing: CCL20/MIP-3 alpha Antibody (206D9.05) [DDX0420P-100] - Blocking migration of CD1a & LC precursors using DDX0430 HRP.](http://images.novusbio.com/fullsize/CCL20-MIP-3-alpha-Antibody-206D9-05-Blocking-Neutralizing-DDX0420P-100-img0003.jpg)
![ELISA: IL-1 beta/IL-1F2 ELISA Kit [Biotin] [NBP1-92702] - Standard curve](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-ELISA-Kit-[Biotin]-ELISA-NBP1-92702-img0001.jpg "ELISA: IL-1 beta/IL-1F2 ELISA Kit [Biotin] [NBP1-92702] - Standard curve")
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0012.jpg "Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)")
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0001.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0002.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0003.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0004.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Carcinoma of Human lung tissue.(Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0005.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0006.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0007.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0008.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0009.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0010.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0011.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (OTI2A12) - Azide and BSA Free [NBP2-71278] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-OTI2A12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71278-img0013.jpg)
![Western Blot: IL-28A/IFN-lambda 2 Antibody (7B9A4) [NBP2-52494] - Analysis using IL28A mouse mAb against SK-Br-3 (1) cell lysate.](http://images.novusbio.com/fullsize/IL-28A-IFN-lambda-2-Antibody-7B9A4-Western-Blot-NBP2-52494-img0005.jpg "Western Blot: IL-28A/IFN-lambda 2 Antibody (7B9A4) [NBP2-52494] - Analysis using IL28A mouse mAb against SK-Br-3 (1) cell lysate.")
![Immunohistochemistry: IL-28A/IFN-lambda 2 Antibody (7B9A4) [NBP2-52494] - Analysis of paraffin-embedded esophageal cancer tissues using IL28A mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/IL-28A-IFN-lambda-2-Antibody-7B9A4-Immunohistochemistry-NBP2-52494-img0002.jpg)
![Western Blot: IL-28A/IFN-lambda 2 Antibody (7B9A4) [NBP2-52494] - Wnalysis using IL28A mAb against HEK293 (1) and IL28A (AA: 1-200)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/IL-28A-IFN-lambda-2-Antibody-7B9A4-Western-Blot-NBP2-52494-img0004.jpg)
![Western Blot: IL-28A/IFN-lambda 2 Antibody (7B9A4) [NBP2-52494] - Analysis using IL28A mAb against human IL28A (AA: 1-200) recombinant protein. (Expected MW is 48.2 kDa)](http://images.novusbio.com/fullsize/IL-28A-IFN-lambda-2-Antibody-7B9A4-Western-Blot-NBP2-52494-img0003.jpg)
![Immunohistochemistry: IL-28A/IFN-lambda 2 Antibody (7B9A4) [NBP2-52494] - Analysis of paraffin-embedded brain tissues using IL28A mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/IL-28A-IFN-lambda-2-Antibody-7B9A4-Immunohistochemistry-NBP2-52494-img0001.jpg)
![ELISA: IL-28A/IFN-lambda 2 Antibody (7B9A4) [NBP2-52494] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng).](http://images.novusbio.com/fullsize/IL-28A-IFN-lambda-2-Antibody-7B9A4-ELISA-NBP2-52494-img0006.jpg)
![Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Western-Blot-NBP2-52448-img0004.jpg "Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against human CSF3 (AA: 1-207) recombinant protein. (Expected MW is 48.2 kDa)")
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of Hela cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Immunofluorescence-NBP2-52448-img0003.jpg)
![Flow Cytometry: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of A549 cells using CSF3 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Flow-Cytometry-NBP2-52448-img0001.jpg)
![Western Blot: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis using CSF3 mAb against HEK293 (1) and CSF3 (AA: 1-207)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Western-Blot-NBP2-52448-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: G-CSF Antibody (8G5F7) [NBP2-52448] - Analysis of A549 cells using CSF3 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin.](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-Immunofluorescence-NBP2-52448-img0002.jpg)
![ELISA: G-CSF Antibody (8G5F7) [NBP2-52448] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng).](http://images.novusbio.com/fullsize/G-CSF-Antibody-8G5F7-ELISA-NBP2-52448-img0006.jpg)
![Western Blot: Galectin-3 Antibody [NBP3-03252] - Analysis of extracts from normal (control) and LGALS3 knockout (KO) HeLa cells, using Galectin-3 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: nonfat dry milk in TBST.](http://images.novusbio.com/fullsize/Galectin-3-Antibody-Knockout-Validated-NBP3-03252-img0004.jpg "<b>Genetic Strategies Validation. </b>Western Blot: Galectin-3 Antibody [NBP3-03252] - Analysis of extracts from normal (control) and LGALS3 knockout (KO) HeLa cells, using Galectin-3 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: nonfat dry milk in TBST.")
![<b>Genetic Strategies Validation. </b>Immunocytochemistry/ Immunofluorescence: Galectin-3 Antibody - Azide and BSA Free [Galectin-3] - Immunofluorescence analysis of U-2 OS cells using [KO Validated] Galectin-3 Rabbit pAb at dilution of 1:100. Secondary antibody: Cy3-conjugated Goat anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp3-03252_rabbit-polyclonal-galectin-3-antibody-5220251628098.jpg)
![Immunocytochemistry/ Immunofluorescence: Galectin-3 Antibody - Azide and BSA Free [Galectin-3] - Immunofluorescence analysis of C6 cells using [KO Validated] Galectin-3 Rabbit pAb at dilution of 1:100. Secondary antibody: Cy3-conjugated Goat anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp3-03252_rabbit-polyclonal-galectin-3-antibody-52202516293915.jpg)
![Immunocytochemistry/ Immunofluorescence: Galectin-3 Antibody - Azide and BSA Free [Galectin-3] - Immunofluorescence analysis of L-929 cells using [KO Validated] Galectin-3 Rabbit pAb at dilution of 1:100. Secondary antibody: Cy3-conjugated Goat anti-Rabbit IgG (H+L) at 1:500 dilution. Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/nbp3-03252_rabbit-polyclonal-galectin-3-antibody-52202516345261.jpg)
![Western Blot: FGF basic/FGF2/bFGF Antibody (8W6M5) [NBP3-15367] - Analysis of extracts of SKOV3 cells, using FGF basic/FGF2/bFGF Rabbit mAb (NBP3-15367) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 60s.](http://images.novusbio.com/fullsize/FGF-basic-FGF2-bFGF-Antibody-8W6M5-Western-Blot-NBP3-15367-img0006.jpg "Western Blot: FGF basic/FGF2/bFGF Antibody (8W6M5) [NBP3-15367] - Analysis of extracts of SKOV3 cells, using FGF basic/FGF2/bFGF Rabbit mAb (NBP3-15367) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 60s.")
![Immunocytochemistry/Immunofluorescence: FGF basic/FGF2/bFGF Antibody (8W6M5) [NBP3-15367] - Immunofluorescence analysis of HeLa cells using FGF basic/FGF2/bFGF Rabbit mAb (NBP3-15367) at dilution of 1:100 (40x lens). Blue: DAPI for nuclear staining.](http://images.novusbio.com/fullsize/FGF-basic-FGF2-bFGF-Antibody-8W6M5-Immunocytochemistry-Immunofluorescence-NBP3-15367-img0005.jpg)
![Immunohistochemistry-Paraffin: FGF basic/FGF2/bFGF Antibody (8W6M5) [NBP3-15367] -Analysis of FGF2 in paraffin-embedded human lung squamous carcinoma tissue using FGF2 Rabbit mAb at dilution of 1:400 (40x lens).Perform high pressure antigen retrieval with 10 mM Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.](http://images.novusbio.com/fullsize/nbp3-15367_rabbit-fgf-basic-fgf2-bfgf-mab-8w6m5-immunohistochemistry-paraffin-238202492320..jpg)
![Immunohistochemistry-Paraffin: FGF basic/FGF2/bFGF Antibody (8W6M5) [NBP3-15367] -Human tonsil tissue using FGF2 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval was performed with 0.01 M citrate buffer (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15367_rabbit-fgf-basic-fgf2-bfgf-mab-8w6m5-immunohistochemistry-paraffin-238202492440..jpg)
![Immunohistochemistry-Paraffin: FGF basic/FGF2/bFGF Antibody (8W6M5) [NBP3-15367] - Human skin tissue using FGF2 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval was performed with 0.01 M citrate buffer (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15367_rabbit-fgf-basic-fgf2-bfgf-mab-8w6m5-immunohistochemistry-paraffin-238202492536..jpg)
![Immunohistochemistry-Paraffin: FGF basic/FGF2/bFGF Antibody (8W6M5) [NBP3-15367] - Human placenta tissue using FGF2 Rabbit mAb at a dilution of 1:200 (40x lens). High pressure antigen retrieval was performed with 0.01 M citrate buffer (pH 6.0) prior to IHC staining.](http://images.novusbio.com/fullsize/nbp3-15367_rabbit-fgf-basic-fgf2-bfgf-mab-8w6m5-immunohistochemistry-paraffin-238202492639..jpg)
![Immunocytochemistry/ Immunofluorescence: p16INK4a/CDKN2A Antibody - BSA Free [NBP3-06986] - Validation of p16INK4a/CDKN2A In HeLa Cells. Immunofluorescent analysis of methanol-fixed HeLa cells labeling p16INK4a/CDKN2A with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/1000 dilution (red) and Hoechst staining (blue). Alpha tubulin was stained with anti-alpha tubulin antibody following by goat anti-mouse IgG secondary antibody (green). Images were captured with confocal microscopy.](http://images.novusbio.com/fullsize/nbp3-06986_rabbit-p16ink4a-cdkn2a-pab-bsa-free-271120242074659.jpg "Immunocytochemistry/ Immunofluorescence: p16INK4a/CDKN2A Antibody - BSA Free [NBP3-06986] - Validation of p16INK4a/CDKN2A In HeLa Cells. Immunofluorescent analysis of methanol-fixed HeLa cells labeling p16INK4a/CDKN2A with at 20 ug/mL, followed by goat anti-rabbit IgG secondary antibody at 1/1000 dilution (red) and Hoechst staining (blue). Alpha tubulin was stained with anti-alpha tubulin antibody following by goat anti-mouse IgG secondary antibody (green). Images were captured with confocal microscopy.")
![<b>Genetic Strategies Validation. </b>Western Blot: p16INK4a/CDKN2A Antibody [NBP3-06986] - Loading: 10 ug of 293 WT cell lysates or CDKN2A KO cell lysates. Antibodies: CDKN2A, NBP3-06986 (2 ug/mL) and beta-actin (1 ug/mL), 1 h incubation at RT in 5% NFDM/TBST. Secondary: Goat](http://images.novusbio.com/fullsize/p16INK4a-CDKN2A-Antibody-Western-Blot-NBP3-06986-img0001.jpg)
![Western Blot: p16INK4a/CDKN2A Antibody [NBP3-06986] - Loading: 15 ug of lysates per lane. Antibodies: NBP3-06986 (2 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/p16INK4a-CDKN2A-Antibody-Western-Blot-NBP3-06986-img0003.jpg)
![Western Blot: p16INK4a/CDKN2A Antibody [NBP3-06986] - Loading: 15 ug of lysates per lane. Antibodies: CDKN2A (2 ug/mL), NBP3-06986 (2 ug/mL) and beta-actin (1 ug/mL), 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/p16INK4a-CDKN2A-Antibody-Western-Blot-NBP3-06986-img0002.jpg)
![Immunohistochemistry: p16INK4a/CDKN2A Antibody - BSA Free [NBP3-06986] - Validation of p16INK4a/CDKN2A in Human Colon Tissue. Immunohistochemical analysis of paraffin-embedded human colon tissue using anti-p16INK4a/CDKN2A antibody at 5 ug/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.](http://images.novusbio.com/fullsize/nbp3-06986_rabbit-p16ink4a-cdkn2a-pab-bsa-free-2711202420115536.gif)
![SDS-Page: Mouse Noggin Protein [NBP2-35098]](http://images.novusbio.com/fullsize/Mouse-Noggin-Protein-SDS-Page-NBP2-35098-img0001.jpg "SDS-Page: Mouse Noggin Protein [NBP2-35098]")
![SDS-Page: Recombinant Human Noggin Protein [NBP2-35079] - man Noggin Protein [NBP2-35079]](http://images.novusbio.com/fullsize/Recombinant-Human-Noggin-Protein-SDS-Page-NBP2-35079-img0002.jpg "SDS-Page: Recombinant Human Noggin Protein [NBP2-35079] - man Noggin Protein [NBP2-35079]")